SE403783B - Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper - Google Patents

Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper

Info

Publication number
SE403783B
SE403783B SE7510812A SE7510812A SE403783B SE 403783 B SE403783 B SE 403783B SE 7510812 A SE7510812 A SE 7510812A SE 7510812 A SE7510812 A SE 7510812A SE 403783 B SE403783 B SE 403783B
Authority
SE
Sweden
Prior art keywords
polyrboinosin
nucleasrist
lysin
hydrophile
interferon
Prior art date
Application number
SE7510812A
Other languages
English (en)
Other versions
SE7510812L (sv
Inventor
H B Levy
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of SE7510812L publication Critical patent/SE7510812L/sv
Publication of SE403783B publication Critical patent/SE403783B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
SE7510812A 1974-09-27 1975-09-26 Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper SE403783B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/509,966 US3952097A (en) 1974-09-27 1974-09-27 Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid

Publications (2)

Publication Number Publication Date
SE7510812L SE7510812L (sv) 1976-03-29
SE403783B true SE403783B (sv) 1978-09-04

Family

ID=24028821

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7510812A SE403783B (sv) 1974-09-27 1975-09-26 Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper

Country Status (13)

Country Link
US (1) US3952097A (sv)
JP (1) JPS5186484A (sv)
BE (1) BE833838A (sv)
CA (2) CA1038375A (sv)
CH (1) CH616432A5 (sv)
DE (1) DE2543214A1 (sv)
FR (1) FR2285893A1 (sv)
GB (1) GB1488209A (sv)
HU (1) HU174918B (sv)
IL (1) IL48099A (sv)
NL (1) NL7511370A (sv)
SE (1) SE403783B (sv)
ZA (1) ZA755865B (sv)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024241A (en) * 1974-09-27 1977-05-17 The United States Of America As Represented By The Secretary Of Health, Education And Welfare Nuclease-resistant hydrophilic complex of polyriboinosinic-polyribocytidylic acid
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4388306A (en) * 1980-06-04 1983-06-14 Merck & Co., Inc. Pharmaceutical composition comprising modified polyriboinosinic-polyribocytidylic acid, for induction of interferon in primates
US4389395A (en) * 1981-01-09 1983-06-21 Lerner A Martin Low molecular weight complex of polyriboinosinic-polyribocytidylic acid and method of inducing interferon
US7229822B1 (en) * 2000-02-29 2007-06-12 Univ Columbia Melanoma differentation associated gene-5 and vectors and cells containing same
PL1898948T3 (pl) * 2005-06-08 2012-06-29 Yisheng Biopharma Singapore Pte Ltd Adiuwant na bazie kwasu poliinozynowego i policytydylowego
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
BRPI0808442A2 (pt) * 2007-03-07 2014-08-05 Nventa Biopharmaceuticals Corp Composições de àcido nucleico de filamento duplo fechado
CN102123724B (zh) 2008-06-19 2018-05-01 变异生技公司 治疗流行性感冒的组合物和方法
US20110097418A1 (en) * 2009-05-29 2011-04-28 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
WO2011005772A1 (en) 2009-07-06 2011-01-13 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
AU2010270722B2 (en) 2009-07-06 2015-06-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
CA2840079C (en) 2010-07-06 2018-07-03 Variation Biotechnologies Inc. Compositions and methods for treating influenza
AU2012205315B2 (en) 2011-01-13 2017-05-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
BR112013017939B1 (pt) 2011-01-13 2022-11-16 Variation Biotechnologies Inc Composição imunogênica liofilizada termoestável, uso e método para preparação da mesma
WO2013104995A2 (en) 2012-01-12 2013-07-18 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
CA2894467A1 (en) 2012-01-27 2013-08-01 Variation Biotechnologies Inc. Methods for preparing thermostable compositions comprising a lipid component and thermolabile therapeutic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) * 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
US3066075A (en) * 1960-07-25 1962-11-27 G W Carnrick Co Compositions comprising amphetamine and carboxymethyl cellulose in chemically combined form
US3493559A (en) * 1967-05-29 1970-02-03 Upjohn Co 2-thiocytosine ribofuranosides
BE757291A (fr) * 1969-10-10 1971-04-09 Smith Kline French Lab Complexe antiviral de arn et d'un polysaccharide
GB1364987A (en) * 1971-06-19 1974-08-29 Merck Patent Gmbh Biologically active two component complexes
BE790953A (fr) * 1971-11-05 1973-05-03 Beecham Group Ltd Matiere biologiquement active
US3853846A (en) * 1973-02-12 1974-12-10 Abbott Lab INOSINE-5 -Carboxylates

Also Published As

Publication number Publication date
IL48099A0 (en) 1975-11-25
FR2285893A1 (fr) 1976-04-23
GB1488209A (en) 1977-10-12
IL48099A (en) 1978-04-30
DE2543214A1 (de) 1976-05-20
CH616432A5 (sv) 1980-03-31
BE833838A (fr) 1976-01-16
HU174918B (hu) 1980-04-28
NL7511370A (nl) 1976-03-30
ZA755865B (en) 1976-08-25
CA1091648B (en) 1980-12-16
SE7510812L (sv) 1976-03-29
US3952097A (en) 1976-04-20
CA1038375A (en) 1978-09-12
FR2285893B1 (sv) 1980-08-08
JPS5186484A (en) 1976-07-29

Similar Documents

Publication Publication Date Title
SE403783B (sv) Sett att framstella ett nukleasresistent hydrofilt komplex av polyrboinosin-polyribocytidylsyra, poly-l-lysin och karboximetylcellulosa med interferoninducerande egenskaper
SE7513990L (sv) Sett att framstella 3-amino-indiazolkarbonsyra-derivat
CS194221B2 (en) Method of producing novel derivatives of aryl-and aralkylimidazole
SE420313B (sv) Forfarande for framstellning av metyl-5-propyltio-2-bensimidazolkarbamat
SE413981B (sv) Tandmedel innehallande ett fortjockningsmedel, vilket er en kombination av hydroxietylcellulosa och natriumkarboximetylcellulosa
SE412592B (sv) Rott fergemne och forfarande att framstella detta fran ett pigment fran en mikroorganism av slektet monascus
SE7510505L (sv) Forfarande for framstellning av ett antitumormedel
SE389981B (sv) Forfarande for framstellning av ett metalliskt filtermaterial
SE405254B (sv) Sett att framstella 7-hydroxi-ostratriener
SE7608206L (sv) Forfarande for framstellning av ett rabiesvaccin
SE404528B (sv) Sett att framstella 1alfa-hydroxisteroider
SE404360B (sv) Sett att framstella 2-nitrobensaldehyd
SE419223B (sv) Sett att framstella ett derivat av gentamin och dess syraadditionssalter
SE406942B (sv) Forfarande for framstellning av ett tverelastiskt fibertyg
JPS5678587A (en) Production of cholesterine oxydase
SE384998B (sv) Forfarande for framstellning av svaveldioxid och/eller svavel fran ett ammoniumsalt av en svaveloxosyra
SE7506388L (sv) Sett att framstella (dl)-13-substituerade sulfinyl-protaglandein-liknande foreningar
SE411447B (sv) Sett att framstella 4-cyklopropylmetylenoxi- 3-klorfenylettiksyra
SE7504587L (sv) Prostansyraderivat och sett for deras framstellning.
SE7508056L (sv) Forfarande for framstellning av ett janer jemte forbettrat faner.
SE7503607L (sv) Forfarande for framstellning av en foregangsform av teofyllin.
SE431203B (sv) Forfarande for framstellning av karbamider genom pyrolys av karbamater
SE7507911L (sv) Sett att framstella nya nbeta-substituerade 8-beta-aminoetylergolin-i-derivat och deras salter.
SE422087B (sv) Forfarande och anordning for framstellning av ett plyschtyg
SE7414896L (sv) Forbettrat forfarande for framstellning av fordermedel